Concepedia

Theingi M. Thway

TM

18

Publications

896

Citations

14

H-Index

2004

Active since

Affiliations

Amgen (United States)(Current)

United States Food and Drug Administration

Bristol-Myers Squibb (United States)

Pfizer (United States)

Roche (Switzerland)

Theingi M. Thway is an author at Amgen (United States) specializing in medicine, pharmacology, and bioanalysis.

Top concepts

Publications per year

2004–2019

18

Publications

18

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Xiaodong Li, Kelly Warmington, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2010 · 233 citations

, , +21

Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca <sup>2+</sup> Mobilization Through Angiotensin Receptor Activation

Theingi M. Thway, Mary-Clare Day, Barbara M. Sanborn et al. · Circulation · 2004 · 130 citations · Full text

2013 White Paper on Recent Issues in Bioanalysis: ‘ <i>Hybrid</i> ’ – The Best of LBA and LCMS

Lauren Stevenson, Fabio Garofolo, Binodh DeSilva et al. · Bioanalysis · 2013 · 74 citations

, , +19

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 3 – Lba, Biomarkers and Immunogenicity)

Susan Richards, Lakshmi Amaravadi, Renuka Pillutla et al. · Bioanalysis · 2016 · 58 citations · Full text

, , +33

Rows per page

1–5 of 18